drugset / Trial / NCT05132660
Treating Early Stage Diabetic Retinopathy
Phase 0
Enrolling by invitation
244 enrolled
VA Office of Research and Development
Emory University · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine if levodopa will slow the appearance of blood vessel changes in the eyes of patients with diabetes. Treatment will be started in patients with diabetes show delays in the electrical activity of the retina when measured non-invasively with a electroretinogram.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levodopa | Small molecule | 100 mg | — |
| Background | Carbidopa | Unknown | 25 mg | — |